BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11340254)

  • 1. Nodal gamma/delta T cell lymphoma in complete remission following allogeneic bone marrow transplantation from an HLA-matched unrelated donor.
    Aoyama Y; Yamane T; Hino M; Ota K; Hasegawa T; Sakamoto C; Nakamae H; Yamamura R; Koh KR; Takubo T; Inoue T; Tsubaki K; Tatsumi N
    Acta Haematol; 2001; 105(1):49-52. PubMed ID: 11340254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ongoing remission after intensive ALL-type chemotherapy in pediatric intestinal T-cell lymphoma.
    Friedrich C; Schrum J; Chott A; Janka-Schaub G; Kabisch H
    Pediatr Blood Cancer; 2010 Apr; 54(4):610-2. PubMed ID: 20049930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatosplenic alphabeta T cell lymphoma.
    Nagai Y; Ikegame K; Mori M; Inoue D; Kimura T; Shimoji S; Togami K; Tabata S; Kurata M; Imai Y; Matsushita A; Nagai K; Ogawa H; Takahashi T
    Int J Clin Oncol; 2010 Apr; 15(2):215-9. PubMed ID: 20217452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatosplenic gamma/delta T-cell lymphoma with isochromosome 7q, translocation t(7;21), and tetrasomy 8 in a 9-year-old girl.
    Rossbach HC; Chamizo W; Dumont DP; Barbosa JL; Sutcliffe MJ
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):154-7. PubMed ID: 11990705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare variety of T-cell lymphoma.
    Pednekar S; Morge V; Rawal S; Korivi D; Ramteke V; Naik K
    J Assoc Physicians India; 2011 Oct; 59():667-8. PubMed ID: 22479752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complete remission achieved by L-asparaginase, vincristine and prednisolone (LVP) therapy in secondary leukemia (M5a type) with an MLL gene rearrangement].
    Tomita N; Fujita H; Koharazawa H; Maruta A; Kodama F; Yamamoto T; Kobayashi S; Okubo T
    Rinsho Ketsueki; 1997 Feb; 38(2):135-41. PubMed ID: 9059068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features.
    Vega F; Medeiros LJ; Bueso-Ramos C; Jones D; Lai R; Luthra R; Abruzzo LV
    Am J Clin Pathol; 2001 Sep; 116(3):410-9. PubMed ID: 11554170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasmacytoid dendritic cell tumor].
    Pérez-Crespo M; Moragón M; Onrubia J; Sevila A; Alfonso R; Miralles J; Requena L
    Actas Dermosifiliogr; 2011 Apr; 102(3):229-31. PubMed ID: 21232729
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases.
    Lu CL; Tang Y; Yang QP; Wang M; Zhao S; Bi CF; Jiang NG; Zhang WY; Liu JP; Xu X; Liu WP
    Hum Pathol; 2011 Dec; 42(12):1965-78. PubMed ID: 21683978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of nasal T-cell lymphoma with a combination of local irradiation and high-dose chemotherapy.
    Sanda T; Lida S; Ito M; Tsuboi K; Miura K; Harada S; Komatsu H; Wakita A; Inagaki H; Ueda R
    Int J Hematol; 2002 Feb; 75(2):195-200. PubMed ID: 11939269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
    Tey SK; Marlton PV; Hawley CM; Norris D; Gill DS
    Am J Hematol; 2008 Apr; 83(4):330-3. PubMed ID: 17876769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CD56- and CD4-positive non-Hodgkin's lymphoma of probable T-cell origin].
    Honda S; Ito Y; Otawa M; Katagiri T; Kuriyama Y; Serizawa H; Ebihara Y; Mukai K; Ohyashiki K
    Rinsho Ketsueki; 2001 May; 42(5):420-5. PubMed ID: 11452463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.
    Tauro S; Dobie D; Richardson G; Hastings M; Mahendra P
    Bone Marrow Transplant; 2000 Nov; 26(9):1017-9. PubMed ID: 11100283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome).
    Motta G; Vianello F; Menin C; De Nicolo A; Agata S; Altavilla G; Pietrogrande F; Girolami A
    Am J Hematol; 2002 Apr; 69(4):272-6. PubMed ID: 11921021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature.
    Domm JA; Thompson M; Kuttesch JF; Acra S; Frangoul H
    J Pediatr Hematol Oncol; 2005 Nov; 27(11):607-10. PubMed ID: 16282893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
    Mittal S; Milner BJ; Johnston PW; Culligan DJ
    Eur J Haematol; 2006 Jun; 76(6):531-4. PubMed ID: 16548918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma/delta T-cell lymphoma with hepatosplenomegaly: report of a case.
    Ohno T; Komada F; Yamaguchi M; Oka K; Nishii K; Tsuda M; Katsuta K; Yamaguchi T; Kita K; Shirakawa S
    Int J Hematol; 1993 Jun; 57(3):269-76. PubMed ID: 8364190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
    Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.
    Schouten HC; Armitage JO; Klassen LW; Vaughan WP; Bierman PJ; Weisenburger D; Kessinger A
    Bone Marrow Transplant; 1989 Jan; 4(1):119-21. PubMed ID: 2466510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angioimmunoblastic T-cell lymphoma with marked polyclonal plasmacytosis in peripheral blood and bone marrow mimicking plasma cell leukemia].
    Mitsuhashi K; Shiseki M; Ishiyama M; Kondo T; Kazama H; Yasunami T; Okamura T; Yoshinaga K; Mori N; Teramura M; Masuda A; Motoji T
    Rinsho Ketsueki; 2011 Jul; 52(7):563-9. PubMed ID: 21821991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.